Apogee Therapeutics Future Growth
Future criteria checks 0/6
Apogee Therapeutics's earnings are forecast to decline at 26.1% per annum while its annual revenue is expected to grow at 94% per year. EPS is expected to decline by 19% per annum.
Key information
-26.1%
Earnings growth rate
-19.0%
EPS growth rate
| Biotechs earnings growth | 28.3% |
| Revenue growth rate | 94.0% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 25 Nov 2024 |
Recent future growth updates
No updates
Recent updates
We're Not Very Worried About Apogee Therapeutics' (NASDAQ:APGE) Cash Burn Rate
Nov 14
Apogee Therapeutics Earnings Preview: APG777's Potential In Atopic Dermatitis
Nov 10We're Not Very Worried About Apogee Therapeutics' (NASDAQ:APGE) Cash Burn Rate
Jun 20Apogee Therapeutics: Infrequent Dosing Advantage In Biotech Play
Jun 18We're Interested To See How Apogee Therapeutics (NASDAQ:APGE) Uses Its Cash Hoard To Grow
Mar 05Apogee Therapeutics' Innovative Leap In Atopic Dermatitis Management
Mar 05We're Not Worried About Apogee Therapeutics' (NASDAQ:APGE) Cash Burn
Nov 21Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -358 | -228 | -248 | 6 |
| 12/31/2025 | N/A | -254 | -212 | -222 | 7 |
| 12/31/2024 | N/A | -172 | -153 | -141 | 7 |
| 9/30/2024 | N/A | -147 | -135 | -133 | N/A |
| 6/30/2024 | N/A | -118 | -111 | -111 | N/A |
| 3/31/2024 | N/A | -104 | -96 | -96 | N/A |
| 12/31/2023 | N/A | -84 | -75 | -75 | N/A |
| 9/30/2023 | N/A | -70 | -56 | -56 | N/A |
| 6/30/2023 | N/A | -69 | -43 | -43 | N/A |
| 3/31/2023 | N/A | -52 | -28 | -28 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: APGE is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: APGE is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: APGE is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: APGE is forecast to have no revenue next year.
High Growth Revenue: APGE is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if APGE's Return on Equity is forecast to be high in 3 years time